Phathom Pharmaceuticals(PHAT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PHAT Phathom Pharmaceuticals

Pre-Mkt 05-15 09:03:33 EDT

13.05

+0.49

+3.90%

盘前12.81

-0.24-1.84%

06:42 EDT

High13.39	Low12.24	Vol1.67M
Open12.63	D1 Closing12.56	Amplitude9.16%
Mkt Cap1.04B	Tradable Cap751.25M	Total Shares79.43M
T/O21.71M	T/O Rate2.91%	Tradable Shares57.57M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PHAT","market":"US","secType":"STK","nameCN":"Phathom Pharmaceuticals","latestPrice":13.05,"timestamp":1778788800000,"preClose":12.56,"halted":0,"volume":1674933,"hourTrading":{"tag":"盘前","latestPrice":12.81,"preClose":13.05,"latestTime":"06:42 EDT","volume":36,"amount":461.16,"timestamp":1778841731194,"change":-0.24,"changeRate":-0.018391,"amplitude":0},"delay":0,"changeRate":0.0390127388535032,"floatShares":57566899,"shares":79430117,"eps":-2.085468,"marketStatus":"Pre-Mkt","change":0.49,"latestTime":"05-15 09:03:33 EDT","open":12.63,"high":13.39,"low":12.24,"amount":21714489.660669,"amplitude":0.091561,"askPrice":12.99,"askSize":253,"bidPrice":12,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-2.085468,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1778851800000},"marketStatusCode":1,"adr":0,"listingDate":1571976000000,"exchange":"NASDAQ","adjPreClose":13.05,"preHourTrading":{"tag":"盘前","latestPrice":12.81,"preClose":13.05,"latestTime":"06:42 EDT","volume":36,"amount":461.16,"timestamp":1778841731194,"change":-0.24,"changeRate":-0.018391,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":13,"preClose":13.05,"latestTime":"19:50 EDT","volume":10587,"amount":138155.85,"timestamp":1778802636758,"change":-0.05,"changeRate":-0.003831,"amplitude":0.003831},"volumeRatio":1.846350299102616,"impliedVol":1.1137,"impliedVolPercentile":0.644},"requestUrl":"/m/hq/s/PHAT/tweets","defaultTab":"tweets","newsList":[{"id":"2634492602","title":"Phathom (PHAT) Is Up 9.4% After Reaffirming 2026 Profitability Timeline And Narrowing Q1 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2634492602","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634492602?lang=en_us&edition=fundamental","pubTime":"2026-05-09 14:45","pubTimestamp":1778309114,"startTime":"0","endTime":"0","summary":"In late April 2026, Phathom Pharmaceuticals reported that its first-quarter net loss narrowed to US$30.37 million from US$94.32 million a year earlier, while maintaining full-year 2026 net revenue guidance of US$320 million to US$345 million and expecting operating profitability, excluding stock-based compensation, to begin in the third quarter of 2026.\nThe company also disclosed a change in how it classifies certain third-party costs starting January 1, 2026, which could make future margins...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phat/phathom-pharmaceuticals/news/phathom-phat-is-up-94-after-reaffirming-2026-profitability-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phat/phathom-pharmaceuticals/news/phathom-phat-is-up-94-after-reaffirming-2026-profitability-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632261481","title":"Phathom to highlight VOQUEZNA at DDW annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2632261481","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632261481?lang=en_us&edition=fundamental","pubTime":"2026-05-01 20:01","pubTimestamp":1777636884,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals will participate in Digestive Disease Week  2026, scheduled for May 2-5 in Chicago.VOQUEZNA  product theater presentation set for May 4 at 12:00 PM CDT.Company will exhibit at DDW 2026 at booth 2511.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL6jMmFq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4585","SG9999014021.USD","LU0314104364.USD","NDAQ","IE00BN0W2W23.USD","SG9999014005.SGD","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014013.SGD","IE00BN0W2V16.EUR","PHAT","IE00BKPKM429.USD","LU2210149790.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","BK4007","BK4588","SG9999014039.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632061648","title":"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Phathom Pharmaceuticals (PHAT) and Zimmer Biomet Holdings (ZBH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632061648","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632061648?lang=en_us&edition=fundamental","pubTime":"2026-05-01 18:40","pubTimestamp":1777632011,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Phathom Pharmaceuticals (PHAT) and Z...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-phathom-pharmaceuticals-phat-and-zimmer-biomet-holdings-zbh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amgen-amgn-phathom-pharmaceuticals-phat-and-zimmer-biomet-holdings-zbh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1023059063.AUD","LU0128525929.USD","LU2242652126.USD","LU1267930490.SGD","BK4585","BK4533","BK4566","LU1267930573.SGD","LU0130517989.USD","LU0128526141.USD","LU0029864427.USD","ZBH","BK4139","BK4082","IE0002270589.USD","LU0029874061.USD","LU0708994859.HKD","LU0310799852.SGD","LU0109394709.USD","LU0889565916.HKD","LU0868494617.USD","LU1983299246.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","LU2242646821.SGD","LU1267930813.SGD","PHAT","LU0320765992.SGD","BK4581","BK4599","LU0130102774.USD","LU1057294990.SGD","LU1571399168.USD","AMGN","LU0477156953.USD","LU0792757196.USD","XBI","LU1201861249.SGD","LU0211328371.USD","BK4588","LU2089984988.USD","SG9999001440.SGD","HCSG","BK4137","LU0122379950.USD","LU0648001328.SGD","XLV","IE00B4R5TH58.HKD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632269502","title":"Phathom Pharmaceuticals Signals Strong Growth on Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2632269502","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632269502?lang=en_us&edition=fundamental","pubTime":"2026-05-01 09:11","pubTimestamp":1777597895,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals, Inc. (($PHAT)) has held its Q1 earnings call. Read on for the main highlights of the call. Phathom Pharmaceuticals’ latest...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/phathom-pharmaceuticals-signals-strong-growth-on-earnings-call?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/phathom-pharmaceuticals-signals-strong-growth-on-earnings-call?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631567635","title":"Phathom Pharmaceuticals Q1 Adj. EPS $(0.18) Beats $(0.32) Estimate, Sales $58.301M Beat $57.028M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2631567635","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631567635?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:01","pubTimestamp":1777546868,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.32) by 43.75 percent. This is a 83.18 percent increase over losses of $(1.07) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/04/52164050/phathom-pharmaceuticals-q1-adj-eps-0-18-beats-0-32-estimate-sales-58-301m-beat-57-028m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631712633","title":"BRIEF-Phathom Pharmaceuticals Q1 Net Income USD -30.369 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631712633","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631712633?lang=en_us&edition=fundamental","pubTime":"2026-04-30 18:59","pubTimestamp":1777546785,"startTime":"0","endTime":"0","summary":"BRIEF-Phathom Pharmaceuticals Q1 Net Income USD -30.369 Million\n\n\nApr 30 (Reuters) - Phathom Pharmaceuticals Q1 revenue USD 58.301 million vs. IBES estimate USD 57 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nPLX0713B6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631635950","title":"Phathom Pharmaceuticals Q1 Adjusted EPS USD -0.18 VS. Ibes Estimate USD -0.32","url":"https://stock-news.laohu8.com/highlight/detail?id=2631635950","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631635950?lang=en_us&edition=fundamental","pubTime":"2026-04-30 18:59","pubTimestamp":1777546740,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nPLX0713B6:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631359696","title":"Phathom Pharmaceuticals Inc - Maintains FY2026 Guidance; Expects Operating Profitability Beginning Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2631359696","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631359696?lang=en_us&edition=fundamental","pubTime":"2026-04-30 18:59","pubTimestamp":1777546740,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nPLX0713B6:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631224633","title":"Phathom Pharmaceuticals Q1 Revenue USD 58.301 Million VS. Ibes Estimate USD 57 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631224633","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631224633?lang=en_us&edition=fundamental","pubTime":"2026-04-30 18:59","pubTimestamp":1777546740,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nPLX0713B6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631332056","title":"Phathom Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2631332056","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631332056?lang=en_us&edition=fundamental","pubTime":"2026-04-30 18:59","pubTimestamp":1777546740,"startTime":"0","endTime":"0","summary":"~1.35 million total VOQUEZNA prescriptions filled to date$58.3 million in Q1 net revenues, a 104% increase year-over-yearQ1 operating expenses of $61.8 million; non-GAAP operating expenses of $56.2 mi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/30/3284660/0/en/Phathom-Pharmaceuticals-Reports-First-Quarter-2026-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1165135440.EUR","LU0347712357.USD","LU2229751404.USD","BK4567","LU1721428933.USD","LU2413666426.HKD","LU2041044095.USD","PHAT","LU1543694498.USD","LU2092937221.SGD","BK4588","A","LU2089279066.USD","BK4585","BK4121","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","LU2413666699.HKD","BK4007","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630589873","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), Pfizer (PFE) and Guardant Health (GH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2630589873","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630589873?lang=en_us&edition=fundamental","pubTime":"2026-04-28 23:20","pubTimestamp":1777389607,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Phathom Pharmaceuticals (PHAT), Pfizer (PFE) and Guardant Health ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-phathom-pharmaceuticals-phat-pfizer-pfe-and-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-phathom-pharmaceuticals-phat-pfizer-pfe-and-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1894683348.USD","PFE","BK4568","IE00B19Z3581.USD","LU1066051498.USD","LU0234572021.USD","BK4592","LABU","PHAT","SG9999002232.USD","SG9999011175.SGD","BK4137","SG9999001176.SGD","SG9999002224.SGD","IE0002270589.USD","LU0868494617.USD","IE00B19Z3B42.SGD","IE000M9KFDE8.USD","BK4551","LU0985481810.HKD","LU1894683264.USD","SG9999013999.USD","SGXZ57979304.SGD","IE00BBT3K403.USD","LU0289739699.SGD","LU0170899867.USD","BK4534","LU0225284248.USD","LU0122379950.USD","LU0306806265.USD","BK4196","LU0321505868.SGD","BK4585","LU1066053197.SGD","BK4581","LU0058720904.USD","SG9999001176.USD","LU0029874061.USD","BK4599","IE00BLSP4452.SGD","LU0128526141.USD","IE00BLSP4239.USD","BK4533","LU0306807586.USD","BK4535","BK4588","LU1057294990.SGD","XBI","BK4550","LU0321505439.SGD","LU0225771236.USD","SG9999003800.SGD","LU1883839398.USD","LU1023059063.AUD","BK4007","LU0456855351.SGD","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628788740","title":"Phathom Pharmaceuticals to report first-quarter results, host webcast and conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2628788740","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628788740?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:03","pubTimestamp":1776686609,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals schedules first-quarter 2026 results release on April 30, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL1rBP2G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","LU2095319765.USD","BK4112","LU2210149790.SGD","PHAT","LU2210150020.SGD","BK4007","IE00B64PRP62.GBP","SG9999014021.USD","BK4588","IE00BGHQF748.EUR","NDAQ","BK4585","IE00BN0W2V16.EUR","SG9999014013.SGD","SG9999014039.USD","LU0314104364.USD","IE00BKPKM429.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628728593","title":"Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2628728593","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628728593?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:00","pubTimestamp":1776686400,"startTime":"0","endTime":"0","summary":"Management to host conference call on Thursday, April 30, 2026, at 8:00 am EDT FLORHAM PARK, N.J., April  20, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/20/3276931/0/en/Phathom-Pharmaceuticals-to-Report-First-Quarter-2026-Financial-Results-and-Provide-Business-Update-on-Thursday-April-30-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627700254","title":"A Look At Phathom Pharmaceuticals (PHAT) Valuation After Recent Stock Momentum Shift","url":"https://stock-news.laohu8.com/highlight/detail?id=2627700254","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627700254?lang=en_us&edition=fundamental","pubTime":"2026-04-15 11:12","pubTimestamp":1776222732,"startTime":"0","endTime":"0","summary":"Stock move puts Phathom Pharmaceuticals in focus\nRecent trading in Phathom Pharmaceuticals (PHAT) has drawn fresh attention to the gastrointestinal drug developer, with investors weighing its current market value against the ongoing commercialization of VOQUEZNA therapies in the United States.\nSee our latest analysis for Phathom Pharmaceuticals.\nAt a share price of $12.67, recent trading has come after a 22.18% 1 month share price return but follows a 19.35% decline year to date and a 165.62%...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phat/phathom-pharmaceuticals/news/a-look-at-phathom-pharmaceuticals-phat-valuation-after-recen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phat/phathom-pharmaceuticals/news/a-look-at-phathom-pharmaceuticals-phat-valuation-after-recen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625305159","title":"Phathom Pharmaceuticals announces annual shareholder meeting via webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2625305159","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625305159?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:01","pubTimestamp":1775563293,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals scheduled annual shareholder meeting to be held virtually on May 19, 2026.Shareholders will vote on election of three Class I directors for terms expiring at 2029 annual meeting.Meeting agenda also includes advisory vote on compensation of named executive officers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phathom Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 07, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL6ns2C5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625767972","title":"Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2625767972","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625767972?lang=en_us&edition=fundamental","pubTime":"2026-04-06 20:00","pubTimestamp":1775476800,"startTime":"0","endTime":"0","summary":"FLORHAM PARK, N.J., April  06, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastroi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/06/3268398/0/en/Phathom-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622876306","title":"BUZZ-U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2622876306","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622876306?lang=en_us&edition=fundamental","pubTime":"2026-03-27 23:48","pubTimestamp":1774626488,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services Workspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL6N40F0XI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PANW","ZBIO","PHAT","PWR","RCKT","HON","GGLS","FIAT","ETN","FCHL","EMR","FTNT","GGLL","CCL.UK","CONX","DISO","ANAB","LTRN","CONI","SAIL","ETR","CRWD","AME","02026","BKSY","TWO","CCL","SST","DDOG","DTCX","WIX","ITRM","DOV","HKIT","FPS","ICOI","AGX","ITRMF","DIS","ARTL","ADMA","VATE","SHPH","PH","VOR","BTGO","IEX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622082150","title":"Phathom Pharmaceuticals Raised to Overweight From Equal-Weight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2622082150","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622082150?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:43","pubTimestamp":1774615380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PHAT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 27, 2026 08:43 ET (12:43 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622823458","title":"BUZZ- Barclays raises Phathom Pharmaceuticals to 'overweight'; shares rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2622823458","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622823458?lang=en_us&edition=fundamental","pubTime":"2026-03-27 19:12","pubTimestamp":1774609939,"startTime":"0","endTime":"0","summary":"BUZZ- Barclays raises Phathom Pharmaceuticals to 'overweight'; shares rise** Gastrointestinal  diseases-focused biopharma Phathom Pharmaceuticals PHAT.O shares rise 2% to $11 premarket** Barclays upgrades stock to \"overweight\" from \"equal-weight\"** Brokerage raises target price to $18 from $16, which represents 66.8% upside from the stock's last close     ** \"We think the combination of a strengthened balance sheet, strong guidance and focused commercial strategy suggests the stock at ~$11 is dislocated from the fundamentals\" - Barclays** Brokerage notes that more targeted GI approach appears positioned to drive better adoption** As of last close, stock has fallen 34.9% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL4N40F0RA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622840221","title":"Phathom Pharmaceuticals Inc. : Barclays Raises Target Price to $18 From $16","url":"https://stock-news.laohu8.com/highlight/detail?id=2622840221","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622840221?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:32","pubTimestamp":1774607567,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nAZN4SNK6E:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.phathompharma.com","stockEarnings":[{"period":"1week","weight":0.067},{"period":"1month","weight":0.03},{"period":"3month","weight":0.0857},{"period":"6month","weight":-0.1037},{"period":"1year","weight":3.0154},{"period":"ytd","weight":-0.2134}],"compareEarnings":[{"period":"1week","weight":0.0227},{"period":"1month","weight":0.0773},{"period":"3month","weight":0.0974},{"period":"6month","weight":0.1135},{"period":"1year","weight":0.2733},{"period":"ytd","weight":0.0972}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.079508},{"month":2,"riseRate":0.571429,"avgChangeRate":0.0658},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.119249},{"month":4,"riseRate":0.571429,"avgChangeRate":0.046876},{"month":5,"riseRate":0.571429,"avgChangeRate":0.00276},{"month":6,"riseRate":0.666667,"avgChangeRate":0.246775},{"month":7,"riseRate":0.666667,"avgChangeRate":0.025067},{"month":8,"riseRate":0.666667,"avgChangeRate":0.15186},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.003613},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.040055},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.100392},{"month":12,"riseRate":0.714286,"avgChangeRate":0.070942}],"exchange":"NASDAQ","name":"Phathom Pharmaceuticals","nameEN":"Phathom Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Phathom Pharmaceuticals(PHAT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Phathom Pharmaceuticals(PHAT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Phathom Pharmaceuticals,PHAT,Phathom Pharmaceuticals股票,Phathom Pharmaceuticals股票老虎,Phathom Pharmaceuticals股票老虎国际,Phathom Pharmaceuticals行情,Phathom Pharmaceuticals股票行情,Phathom Pharmaceuticals股价,Phathom Pharmaceuticals股市,Phathom Pharmaceuticals股票价格,Phathom Pharmaceuticals股票交易,Phathom Pharmaceuticals股票购买,Phathom Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Phathom Pharmaceuticals(PHAT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Phathom Pharmaceuticals(PHAT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}